What is the share price of Ngl Fine Chem Ltd (NGLFINE) today?
The share price of NGLFINE as on 2nd March 2026 is ₹2402.20. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Ngl Fine Chem Ltd (NGLFINE) share?
The past returns of Ngl Fine Chem Ltd (NGLFINE) share are- Past 1 week: 0.43%
- Past 1 month: 38.86%
- Past 3 months: 81.26%
- Past 6 months: 63.16%
- Past 1 year: 132.75%
- Past 3 years: 78.15%
- Past 5 years: 28.53%
What are the peers or stocks similar to Ngl Fine Chem Ltd (NGLFINE)?
The peers or stocks similar to Ngl Fine Chem Ltd (NGLFINE) include:What is the dividend yield % of Ngl Fine Chem Ltd (NGLFINE) share?
The current dividend yield of Ngl Fine Chem Ltd (NGLFINE) is 0.07.What is the market cap of Ngl Fine Chem Ltd (NGLFINE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Ngl Fine Chem Ltd (NGLFINE) is ₹1484.08 Cr as of 2nd March 2026.What is the 52 week high and low of Ngl Fine Chem Ltd (NGLFINE) share?
The 52-week high of Ngl Fine Chem Ltd (NGLFINE) is ₹2575 and the 52-week low is ₹980.What is the PE and PB ratio of Ngl Fine Chem Ltd (NGLFINE) stock?
The P/E (price-to-earnings) ratio of Ngl Fine Chem Ltd (NGLFINE) is 70.24. The P/B (price-to-book) ratio is 5.25.Which sector does Ngl Fine Chem Ltd (NGLFINE) belong to?
Ngl Fine Chem Ltd (NGLFINE) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Ngl Fine Chem Ltd (NGLFINE) shares?
You can directly buy Ngl Fine Chem Ltd (NGLFINE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Ngl Fine Chem Ltd
NGLFINE Share Price
NSENGLFINE Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
NGLFINE Performance & Key Metrics
NGLFINE Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 42.28 | 5.25 | 0.07% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.67 | 5.79 | 0.58% |
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
NGLFINE Company Profile
NGL Fine-Chem Limited is manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health.
NGLFINE Sentiment Analysis
NGLFINE Sentiment Analysis
NGLFINE Stock Summary · November 2025
The company is witnessing a steady recovery in demand, particularly in the Indian and Asia Pacific markets, which has positively impacted revenue and EBITDA for the recent quarter. However, rising operational costs, including a significant increase in outsourcing and salary expenses, have pressured profit margins, leading to a slight decline in profit after tax. While management remains optimistic about future growth driven by ongoing capital projects and strategic market expansions, particularly in the U.S. and EU, regulatory approvals pose a challenge. The company is focused on maintaining a disciplined capital expenditure program to enhance production capacity, despite the complexities of navigating a competitive landscape and managing debt effectively. Overall, while the outlook is cautiously optimistic, achieving ambitious revenue targets may prove challenging amidst these operational hurdles.
NGLFINE Stock Growth Drivers
NGLFINE Stock Growth Drivers
7Strong Financial Performance
NGL Fine-Chem Limited has reported significant financial growth, with Q2 FY '26 revenue from operations
Operational Capacity and Market Demand
The company has resumed outsourcing to meet strong demand, ensuring timely delivery and efficient customer
NGLFINE Stock Challenges
NGLFINE Stock Challenges
4Decline in EBITDA Margins
The company has experienced a significant decline in EBITDA margins since FY '23, despite a
Challenges in Capacity Measurement and Market Competition
The company faces challenges in defining production capacity in relation to sales due to the
NGLFINE Forecast
NGLFINE Forecasts
Price
Revenue
Earnings
NGLFINE Company Revenue Forecast
NGLFINE Company Revenue Forecast
All values in ₹ cr.
All values in ₹ cr.
NGLFINE Stock EPS (Earnings Per Share) Forecast
NGLFINE Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
NGLFINE
NGLFINE
Income
Balance Sheet
Cash Flow
NGLFINE Income Statement
NGLFINE Income Statement
| Quarter | sep 2023 | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 83.40 | 91.63 | 103.44 | 96.64 | 98.60 | 88.97 | 94.01 | 110.54 | 122.31 | 132.12 | ||||||||||
| Operating & Other expenses | 66.21 | 74.08 | 83.94 | 81.40 | 81.93 | 84.00 | 88.65 | 93.21 | 103.10 | 105.20 | ||||||||||
| EBITDA | 17.19 | 17.55 | 19.50 | 15.24 | 16.67 | 4.97 | 5.36 | 17.33 | 19.21 | 26.92 | ||||||||||
| Depreciation/Amortization | 2.89 | 2.94 | 2.92 | 3.00 | 3.03 | 3.10 | 3.32 | 4.27 | 5.09 | 5.18 | ||||||||||
| PBIT | 14.30 | 14.61 | 16.58 | 12.24 | 13.64 | 1.87 | 2.04 | 13.06 | 14.12 | 21.74 | ||||||||||
| Interest & Other Items | 0.36 | 0.28 | 0.49 | 0.44 | 0.32 | 0.60 | 0.97 | 1.22 | 1.16 | 1.07 | ||||||||||
| PBT | 13.94 | 14.33 | 16.09 | 11.80 | 13.32 | 1.27 | 1.07 | 11.84 | 12.96 | 20.67 | ||||||||||
| Taxes & Other Items | 3.46 | 4.30 | 3.77 | 2.57 | 3.52 | -0.01 | 0.52 | 2.60 | 3.34 | 4.98 | ||||||||||
| Net Income | 10.48 | 10.03 | 12.32 | 9.23 | 9.80 | 1.28 | 0.55 | 9.24 | 9.62 | 15.69 | ||||||||||
| EPS | 16.96 | 16.24 | 19.95 | 14.92 | 15.88 | 2.07 | 0.88 | 14.96 | 15.58 | 25.40 |
NGLFINE Company Updates
Investor Presentation
NGLFINE Stock Peers
NGLFINE Past Performance & Peer Comparison
NGLFINE Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Ngl Fine Chem Ltd | 70.24 | 5.25 | 0.07% |
| Sun Pharmaceutical Industries Ltd | 38.47 | 5.80 | 0.91% |
| Torrent Pharmaceuticals Ltd | 77.37 | 19.48 | 0.73% |
| Cipla Ltd | 20.71 | 3.49 | 1.18% |
NGLFINE Stock Price Comparison
Compare NGLFINE with any stock or ETFNGLFINE Holdings
NGLFINE Shareholdings
NGLFINE Promoter Holdings Trend
NGLFINE Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
NGLFINE Institutional Holdings Trend
NGLFINE Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
NGLFINE Shareholding Pattern
NGLFINE Shareholding Pattern
NGLFINE Shareholding History
NGLFINE Shareholding History
smallcases containing NGLFINE stock
smallcases containing NGLFINE stock
Looks like this stock is not in any smallcase yet.
NGLFINE Events
NGLFINE Events
NGLFINE Dividend Trend
NGLFINE has increased or maintained dividend levels over the last 5 years
Current dividend yield is 0.07%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹0.73 every year
Dividends
Corp. Actions
Announcements
Legal Orders
NGLFINE Dividend Trend
NGLFINE has increased or maintained dividend levels over the last 5 years
Current dividend yield is 0.07%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹0.73 every year
NGLFINE Upcoming Dividends
NGLFINE Upcoming Dividends
No upcoming dividends are available
NGLFINE Past Dividends
NGLFINE Past Dividends
Cash Dividend
Ex DateEx DateAug 12, 2025
Dividend/Share
₹1.75
Ex DateEx Date
Aug 12, 2025
Cash Dividend
Ex DateEx DateAug 16, 2024
Dividend/Share
₹1.75
Ex DateEx Date
Aug 16, 2024
Cash Dividend
Ex DateEx DateAug 18, 2023
Dividend/Share
₹1.75
Ex DateEx Date
Aug 18, 2023
Cash Dividend
Ex DateEx DateJun 22, 2022
Dividend/Share
₹1.75
Ex DateEx Date
Jun 22, 2022
Cash Dividend
Ex DateEx DateAug 12, 2021
Dividend/Share
₹1.75
Ex DateEx Date
Aug 12, 2021
NGLFINE Stock News & Opinions
NGLFINE Stock News & Opinions
Net profit of NGL Fine Chem rose 1125.78% to Rs 15.69 crore in the quarter ended December 2025 as against Rs 1.28 crore during the previous quarter ended December 2024. Sales rose 43.11% to Rs 127.51 crore in the quarter ended December 2025 as against Rs 89.10 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales127.5189.10 43 OPM %17.505.71 - PBDT25.854.36 493 PBT20.671.27 1528 NP15.691.28 1126 Powered by Capital Market - Live
NGL Fine-Chem will hold a meeting of the Board of Directors of the Company on 3 February 2026.Powered by Capital Market - Live
Net profit of NGL Fine Chem declined 1.83% to Rs 9.63 crore in the quarter ended September 2025 as against Rs 9.81 crore during the previous quarter ended September 2024. Sales rose 28.65% to Rs 120.26 crore in the quarter ended September 2025 as against Rs 93.48 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales120.2693.48 29 OPM %14.2712.36 - PBDT18.0516.36 10 PBT12.9613.33 -3 NP9.639.81 -2 Powered by Capital Market - Live
NGL Fine-Chem will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live
Net profit of NGL Fine Chem rose 0.22% to Rs 9.24 crore in the quarter ended June 2025 as against Rs 9.22 crore during the previous quarter ended June 2024. Sales rose 14.81% to Rs 104.19 crore in the quarter ended June 2025 as against Rs 90.75 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales104.1990.75 15 OPM %10.5410.31 - PBDT16.1114.79 9 PBT11.8411.79 0 NP9.249.22 0 Powered by Capital Market - Live
NGL Fine-Chem will hold a meeting of the Board of Directors of the Company on 1 August 2025.Powered by Capital Market - Live
NGL Fine-Chem announced that the 44th Annual General Meeting(AGM) of the company will be held on 19 May 2025.Powered by Capital Market - Live
NGL Fine Chem has fixed 12 August 2025 as record date for payment of final dividend. The dividend will be paid on or after 26 August 2025. Powered by Capital Market - Live
NGL Fine-Chem announced that the Board of Directors of the Company at its meeting held on 22 May 2025, inter alia, have recommended the final dividend of Rs 1.75 per equity Share (i.e. 35%) , subject to the approval of the shareholders.Powered by Capital Market - Live
Net profit of NGL Fine Chem declined 95.62% to Rs 0.54 crore in the quarter ended March 2025 as against Rs 12.32 crore during the previous quarter ended March 2024. Sales declined 4.80% to Rs 94.97 crore in the quarter ended March 2025 as against Rs 99.76 crore during the previous quarter ended March 2024. For the full year,net profit declined 48.89% to Rs 21.12 crore in the year ended March 2025 as against Rs 41.32 crore during the previous year ended March 2024. Sales rose 8.73% to Rs 368.26 crore in the year ended March 2025 as against Rs 338.69 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales94.9799.76 -5 368.26338.69 9 OPM %6.6515.86 -9.2015.73 - PBDT4.3819.01 -77 40.1766.06 -39 PBT1.0616.09 -93 27.7154.42 -49 NP0.5412.32 -96 21.1241.32 -49 Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 19.49%, vs industry avg of 9.88%
Over the last 5 years, market share increased from 0.06% to 0.09%
Over the last 5 years, net income has grown at a yearly rate of 20.4%, vs industry avg of 19.69%